Health
Study identifies new therapeutic targets for treatment of obesity and type 2 diabetes – News-Medical.Net
The GIP receptor in the central nervous system plays a crucial role in the regulation of body weight and food intake.
The GIP receptor in the central nervous system plays a crucial role in the regulation of body weight and food intake. This is shown by a recent study by Helmholtz Zentrum München, ETH Zurich and the German Center for Diabetes Research (DZD). The study, which has now been published in ‘Cell Metabolism’, identifies new targets for the development of a drug treatment for obesity and type 2 diabetes.
Dual-agonists targeting the receptors for Glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic…
-
Noosa News21 hours agoBrisbane’s Triffid forces redesign of $1.5 billion tower project
-
Noosa News24 hours agoMan dies in Gold Coast after rolling trailer pins him to lamp-post
-
General20 hours agoSussan Ley’s office says Bridget McKenzie made false claims about cabinet solidarity
-
General17 hours agoIsraeli forces open fire towards diplomatic delegation touring Jenin in the northern West Bank